Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults

Blood

Volumn 118, Issue 15, 2011, Pages 4036-4040

  Crowther, Mark A ^a,b   Chan, Y L Tracey ^a   Garbett, Ian K ^a   Lim, Wendy ^b   Vickers, Mark A ^c  

^a WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b ST JOSEPH S HOSPITAL   (Canada)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; HEMOGLOBIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADD ON THERAPY; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; CHRONIC LYMPHATIC LEUKEMIA; COOMBS TEST; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED PRACTICE; FOLLOW UP; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIMB ISCHEMIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 80054110272     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-347708     Document Type: Review

References (32)

1. Lechner K, Jager U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010;116(11):1831- 1838.
2. Neunert C, LimW, Crowther M, Cohen A, Solberg L, Crowther M. Clinical guideline update on Immune thrombocytopenia: an evidence based practice guideline developed by the American Society of Hematology. Blood. 2011;117(16):4190-4207.
3. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490-1498.
4. Dameshek W, Rosenthal MC, Schwartz LI. The treatment of aquired haemolytic anaemia with adrenocorticotrophic hormone. N Engl J Med. 1951;244(4):117-127.
5. Treatment of blood disorders with ACTH and cortisone. Br Med J. 1955;2(4937):455-457.
6. Allgood JW, Chaplin J. Idiopathic acquired autoimmune hemolytic anemia. A review of fortyseven cases treated from 1955 through 1965. Am J Med. 1967;43(2):254-273.
7. Zupanska B, Sylwestrowicz T, Pawelski S. The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia. 1981;14(4):425-433. (Pubitemid 12103250)
8. Pignon J-M, Poirson E, Rochant H. Danazol in autoimmune haemolytic anaemia. Br J Haematol. 1993;83(2):343-345. (Pubitemid 23060935)
9. Akpek G, McAneny D,Weintraub L. Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. Am J Hematol. 1999;61(2):98-102. (Pubitemid 29252385)
10. Balague C, Targarona EM, Cerdan G, et al. Longterm outcome after laparoscopic splenectomy related to hematologic diagnosis. Surg Endoscop. 2004;18(8):1283-1287. (Pubitemid 39014874)
11. Chertkow G, Dacie JV. Results of splenectomy in auto-immune haemolytic anaemia. Br J Haematol. 1956;2(3):237-249.
12. Coon WW. Splenectomy in the treatment of hemolytic anemia. Arch Surg. 1985;120(5):625-628. (Pubitemid 15053421)
13. Grant IR, Parsons SW, Johnstone JMS,Wood JK. Elective splenectomy in haematological disorders. Ann R Coll Surg Engl. 1988;70(1):29-33. (Pubitemid 18096294)
14. Musser G, Lazar G, Hocking W, Busuttil W. Splenectomy for hematologic disease. The UCLA experience with 306 patients. Ann Surg. 1984; 200(1):40-45. (Pubitemid 14086684)
15. Dierickx D, Verhoef G, Van HA, et al. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. J Intern Med. 2009;266(5): 484-491.
16. Bussone G, Ribeiro E, Dechartres A, et al. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol. 2009; 84(3):153-157.
17. D'Arena G, Califano C, Annunziata M, et al. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. Eur J Haematol. 2007;79(1):53-58. (Pubitemid 47000611)
18. Willis F, Marsh JCW, Bevan DH, et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol. 2001; 114(4):891-898. (Pubitemid 32953751)
19. Worlledge SM, Brain MC, Cooper AC, Hobbs JR, Dacie JV. Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med. 1968;61(12):1312-1315.
20. Ahn YS, Harrington WJ, Mylvaganam R. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med. 1985;102(3):298-301. (Pubitemid 15101856)
21. Ahn YS. Efficacy of danazol in hematologic disorders. Acta Haematol. 1990;84(3):122-129. (Pubitemid 20361936)
22. Hershko C, Sonnenblick M, Ashkenazi J. Control of corticosteroid- resistant autoimmune haemolytic anaemia by cyclosporine. Br J Haematol. 1990;76(3):436-437. (Pubitemid 20367859)
23. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for retractory autoimmnune hemolytic anemia. Blood. 2002;100(2):704-706. (Pubitemid 34761141)
24. Howard J, Hoffbrand AV, Prentice HG, Mehta A. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and autoimmune thrombocytopenia purpura. Br J Haematol. 2002;117(3):712-715. (Pubitemid 34539252)
25. Kotb R, Pinganaud C, Trichet C, et al. Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single center preliminary study. Eur J Haematol. 2005;75(1):60-64. (Pubitemid 40873963)
26. Ahn YS, Harrington WJ, Byrnes JJ. Treatment of autoimmune haemolytic anemia with Vinca-loaded platelets. JAMA. 1983;249(16):2189-2194. (Pubitemid 13118675)
27. Shvidel L, Sigler E, Shtalrid M, Berrebi A. Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures. Am J Hematol. 2006; 81(6):423-425. (Pubitemid 43787929)
28. Mitchell CA, Lim SG, Street AM. High dose intravenous gammaglobulin in immune haematological disease. Dev Biol Stand. 1987;67(1):267-272. (Pubitemid 17096346)
29. Salama A, Mahn I, Neuzner J. IgG therapy in autoimmune haemolytic anaemia of warm type. Blut. 1984;48(6):391-392. (Pubitemid 14094304)
30. Mueller-Eckhardt C, Salama A, Mahn I. Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol. 1985;34(5):394- 400.
31. Ruivard M, Tournilhac O, Montel S, et al. Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case-control study. J Clin Apher. 2006;21(3):202-206. (Pubitemid 46591219)
32. Passweg JR, Rabusin M, Musso M, et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol. 2004; 125(6):749-755. (Pubitemid 38813601)